The Global Fund to fight AIDS, Tuberculosis and Malaria

The Global Fund to fight AIDS, Tuberculosis and Malaria’ project seeks to address the key programmatic gaps, in particularly of finding the ‘missing persons with TB’ and addressing other related health system challenges towards achieving greater impact.

The key strategic focus of the project is to:

  1. Find the missing persons with TB
  2. Address the huge gap in multidrug-resistant (MDR-)/ rifampicin-resistant (RR) TB detection and treatment in enrolment
  3. Address the low TB service coverage by rapidly expanding TB services
  4. Pursue an ambitious scale-up of TB services in the private-for-profit (PFP) facilities
  5. Address the suboptimal access to and utilization of GeneXpert MTB/RIF servicesAddress issues of vulnerability by increasing efforts at case finding among key and vulnerable populations
  6. Increase access to TB/HIV services
  7. Address health system weaknesses and finance gaps that have contributed to the limited performance of the NTP to date.

In 2019 we supported the patent medicine vendors, community pharmacists and traditional birth attendants in showing an increase in referrals of presumptive TB patients. We also supported the private-for-profit sector in their diagnosis of presumptive TB patients. The project continued to support these facilities and groups with mentoring, supportive supervision and onsite data verification.

Country: Nigeria

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.